160 related articles for article (PubMed ID: 29227101)
1. The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity.
Košak U; Brus B; Knez D; Žakelj S; Trontelj J; Pišlar A; Šink R; Jukič M; Živin M; Podkowa A; Nachon F; Brazzolotto X; Stojan J; Kos J; Coquelle N; Sałat K; Colletier JP; Gobec S
J Med Chem; 2018 Jan; 61(1):119-139. PubMed ID: 29227101
[TBL] [Abstract][Full Text] [Related]
2. Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
Košak U; Brus B; Knez D; Šink R; Žakelj S; Trontelj J; Pišlar A; Šlenc J; Gobec M; Živin M; Tratnjek L; Perše M; Sałat K; Podkowa A; Filipek B; Nachon F; Brazzolotto X; Więckowska A; Malawska B; Stojan J; Raščan IM; Kos J; Coquelle N; Colletier JP; Gobec S
Sci Rep; 2016 Dec; 6():39495. PubMed ID: 28000737
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, in vivo and in vitro studies of 1,2,3,4-tetrahydro-9H-carbazole derivatives, highly selective and potent butyrylcholinesterase inhibitors.
Ghobadian R; Esfandyari R; Nadri H; Moradi A; Mahdavi M; Akbarzadeh T; Khaleghzadeh-Ahangar H; Edraki N; Sharifzadeh M; Amini M
Mol Divers; 2020 Feb; 24(1):211-223. PubMed ID: 30927138
[TBL] [Abstract][Full Text] [Related]
4. Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes.
Pajk S; Knez D; Košak U; Zorović M; Brazzolotto X; Coquelle N; Nachon F; Colletier JP; Živin M; Stojan J; Gobec S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):498-505. PubMed ID: 31914836
[TBL] [Abstract][Full Text] [Related]
5. Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease.
Meden A; Knez D; Jukič M; Brazzolotto X; Gršič M; Pišlar A; Zahirović A; Kos J; Nachon F; Svete J; Gobec S; Grošelj U
Chem Commun (Camb); 2019 Mar; 55(26):3765-3768. PubMed ID: 30864579
[TBL] [Abstract][Full Text] [Related]
6. Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.
Brus B; Košak U; Turk S; Pišlar A; Coquelle N; Kos J; Stojan J; Colletier JP; Gobec S
J Med Chem; 2014 Oct; 57(19):8167-79. PubMed ID: 25226236
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
8. Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation.
Lu X; Yang H; Li Q; Chen Y; Li Q; Zhou Y; Feng F; Liu W; Guo Q; Sun H
Bioorg Chem; 2019 Apr; 85():117-127. PubMed ID: 30605885
[TBL] [Abstract][Full Text] [Related]
9. The exploration of thienothiazines as selective butyrylcholinesterase inhibitors.
Karlsson D; Fallarero A; Brunhofer G; Mayer C; Prakash O; Mohan CG; Vuorela P; Erker T
Eur J Pharm Sci; 2012 Aug; 47(1):190-205. PubMed ID: 22683890
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations.
Zhou Y; Lu X; Yang H; Chen Y; Wang F; Li J; Tang Z; Cheng X; Yang Y; Xu L; Xia Q
Molecules; 2019 Nov; 24(23):. PubMed ID: 31757047
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and In Vitro Screening of Novel Heterocyclic β-d-Gluco- and β-d-Galactoconjugates as Butyrylcholinesterase Inhibitors.
Baumann K; Kordić L; Močibob M; Šinko G; Tomić S
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382668
[TBL] [Abstract][Full Text] [Related]
12. N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.
Košak U; Knez D; Coquelle N; Brus B; Pišlar A; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S
Bioorg Med Chem; 2017 Jan; 25(2):633-645. PubMed ID: 27908752
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode.
Sawatzky E; Wehle S; Kling B; Wendrich J; Bringmann G; Sotriffer CA; Heilmann J; Decker M
J Med Chem; 2016 Mar; 59(5):2067-82. PubMed ID: 26886849
[TBL] [Abstract][Full Text] [Related]
14. Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT
Więckowska A; Kołaczkowski M; Bucki A; Godyń J; Marcinkowska M; Więckowski K; Zaręba P; Siwek A; Kazek G; Głuch-Lutwin M; Mierzejewski P; Bienkowski P; Sienkiewicz-Jarosz H; Knez D; Wichur T; Gobec S; Malawska B
Eur J Med Chem; 2016 Nov; 124():63-81. PubMed ID: 27560283
[TBL] [Abstract][Full Text] [Related]
15. Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection.
Li Q; Chen Y; Xing S; Liao Q; Xiong B; Wang Y; Lu W; He S; Feng F; Liu W; Chen Y; Sun H
J Med Chem; 2021 May; 64(10):6856-6876. PubMed ID: 33973470
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.
Rosenberry TL; Brazzolotto X; Macdonald IR; Wandhammer M; Trovaslet-Leroy M; Darvesh S; Nachon F
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186056
[TBL] [Abstract][Full Text] [Related]
17. Pteryxin - A promising butyrylcholinesterase-inhibiting coumarin derivative from Mutellina purpurea.
Orhan IE; Senol FS; Shekfeh S; Skalicka-Wozniak K; Banoglu E
Food Chem Toxicol; 2017 Nov; 109(Pt 2):970-974. PubMed ID: 28286309
[TBL] [Abstract][Full Text] [Related]
18. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
Katalinić M; Rusak G; Domaćinović Barović J; Sinko G; Jelić D; Antolović R; Kovarik Z
Eur J Med Chem; 2010 Jan; 45(1):186-92. PubMed ID: 19879672
[TBL] [Abstract][Full Text] [Related]
19. Evaluating Fmoc-amino acids as selective inhibitors of butyrylcholinesterase.
Gonzalez J; Ramirez J; Schwans JP
Amino Acids; 2016 Dec; 48(12):2755-2763. PubMed ID: 27522651
[TBL] [Abstract][Full Text] [Related]
20. From tryptophan-based amides to tertiary amines: Optimization of a butyrylcholinesterase inhibitor series.
Meden A; Knez D; Brazzolotto X; Nachon F; Dias J; Svete J; Stojan J; Grošelj U; Gobec S
Eur J Med Chem; 2022 Apr; 234():114248. PubMed ID: 35299116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
